These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 7502908)

  • 1. Study of salivary and serum secretory IgA in IgA mesangial nephritis and primary glomerulonephritis.
    Rostoker G; Terzidis H; Petit-Phar M; Lang P; Weil B
    Adv Exp Med Biol; 1995; 371B():835-7. PubMed ID: 7502908
    [No Abstract]   [Full Text] [Related]  

  • 2. Secretory IgA are elevated in both saliva and serum of patients with various types of primary glomerulonephritis.
    Rostoker G; Terzidis H; Petit-Phar M; Meillet D; Lang P; Dubert JM; Lagrue G; Weil B
    Clin Exp Immunol; 1992 Nov; 90(2):305-11. PubMed ID: 1424290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucosal immunity in adult primary glomerulonephritis. I. Evaluation of salivary IgA subclasses and components.
    Rostoker G; Pech MA; Petit-Phar M; BenMaadi A; Cholin S; Lang P; Dubert JM; Weil B; Lagrue G
    Nephron; 1990; 54(1):42-6. PubMed ID: 2296344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of intestinal permeability in IgA mesangial nephritis and primary glomerulonephritis.
    Rostoker G; Wirquin V; Terzidis H; Chaumette MT; Lang P; Weil B
    Adv Exp Med Biol; 1995; 371B():839-41. PubMed ID: 7502909
    [No Abstract]   [Full Text] [Related]  

  • 5. The value of immunofluorescence in the diagnosis of glomerulonephritis not related to systemic diseases.
    Morel-Maroger L; Adam C; Richet G
    Perspect Nephrol Hypertens; 1973; 1 Pt 1():81-110. PubMed ID: 4143636
    [No Abstract]   [Full Text] [Related]  

  • 6. [The immunosuppressive therapy of chronic (Bright's) nephritis].
    Krasnova TN; Shilov EM
    Ter Arkh; 1993; 65(6):88-93. PubMed ID: 8378860
    [No Abstract]   [Full Text] [Related]  

  • 7. Evolution of mesangial IgM nephropathy into focal segmental glomerulosclerosis.
    Jennette JC
    Am J Nephrol; 1981; 1(3-4):222. PubMed ID: 7349055
    [No Abstract]   [Full Text] [Related]  

  • 8. [Immunosuppressive therapy of glomerulonephritis--controlled studies].
    Ferrari P; Frey FJ
    Ther Umsch; 1993 Feb; 50(2):119-29. PubMed ID: 8456416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated salivary IgA in patients with IgA nephropathy.
    Yamabe H; Ozawa K; Fukushi K; Ohsawa H; Chiba N; Onodera K
    Nephron; 1987; 45(2):176. PubMed ID: 3561633
    [No Abstract]   [Full Text] [Related]  

  • 10. Circulating antibodies recognising oxidatively-modified low-density lipoproteins in patients with IgA nephropathy, membranous glomerulonephritis and focal glomerulosclerosis.
    Fornasieri A; Perugini C; Seccia M; Napodano P; D'Amico G; Bellomo G
    J Nephrol; 2002; 15(4):349-57. PubMed ID: 12243363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunotherapy of primary glomerulonephritis].
    Ritz E; Mickisch O
    Internist (Berl); 1989 Mar; 30(3):180-95. PubMed ID: 2654060
    [No Abstract]   [Full Text] [Related]  

  • 12. Salivary and serum IgA subclasses in IgA nephropathy.
    Rostoker G; Pilatte Y; Weil B
    Nephrol Dial Transplant; 1994; 9(1):112-3. PubMed ID: 8177469
    [No Abstract]   [Full Text] [Related]  

  • 13. T cell subsets in glomerulonephritis.
    Lin CY; Yang YM; Fu YK
    Int J Pediatr Nephrol; 1986; 7(2):63-8. PubMed ID: 3487514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pathogenesis of immune glomerulonephritis].
    Rougier JP; Ronco P
    Rev Prat; 2003 Nov; 53(18):1998-2004. PubMed ID: 15008213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IgA nephropathy associated with disseminated tuberculosis.
    Cohen AJ; Rosenstein ED
    Arch Intern Med; 1985 Mar; 145(3):554-6. PubMed ID: 3977523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunological analysis of the primary renal diseases and lupus nephritis].
    Osaki K; Uomizu K; Otsuka H; Morita T; Uemura S; Harada R; Otsuji Y; Hashimoto S
    Nihon Jinzo Gakkai Shi; 1985 Jan; 27(1):33-41. PubMed ID: 4010062
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinico-pathological evaluation of mesangial IgA deposition of minimal change with nephrotic syndrome].
    Hamaguchi K; Tuchida H; Suzuki S; Miura Y; Nakazawa R; Suhara Y; Mimura N
    Nihon Jinzo Gakkai Shi; 1990 Oct; 32(10):1071-7. PubMed ID: 2287099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum IgE in primary glomerular diseases.
    Lagrue G; Laurent J; Hirbec G; Ansquer JC; Noirot C; Laurent G; Nebout T; Kestenbaum S
    Nephron; 1984; 36(1):5-9. PubMed ID: 6691002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence & significance of IgM mesangial deposits in relapsing idiopathic nephrotic syndrome of childhood.
    Bhuyan UN; Srivastava RN
    Indian J Med Res; 1987 Jul; 86():53-60. PubMed ID: 3692560
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinicopathological significance of intratubular giant macrophages in progressive glomerulonephritis.
    Oda T; Hotta O; Taguma Y; Kitamura H; Sugai H; Onodera S; Horigome I; Suzuki K; Shouji Y; Furuta T; Chiba S; Yoshizawa N; Nagura H
    Kidney Int; 1998 May; 53(5):1190-200. PubMed ID: 9573533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.